OMRX Stock Overview
Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Orthometrix, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.000001 |
| 52 Week High | US$0.0001 |
| 52 Week Low | US$0.000001 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 3 Year Change | -99.95% |
| 5 Year Change | -99.98% |
| Change since IPO | -100.00% |
Recent News & Updates
No updates
Recent updates
No updates
Shareholder Returns
| OMRX | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 0% | -2.9% | -3.2% |
| 1Y | n/a | -3.7% | 19.3% |
Return vs Industry: Insufficient data to determine how OMRX performed against the US Medical Equipment industry.
Return vs Market: Insufficient data to determine how OMRX performed against the US Market.
Price Volatility
| OMRX volatility | |
|---|---|
| OMRX Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 7.4% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.5% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: OMRX has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OMRX's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | n/a | Reynald Bonmati | n/a |
Orthometrix, Inc. develops technologies, procedures, and devices to help increase musculoskeletal mobility, as well as non-invasive technologies to treat the pain associated with osteoarthritis, plantar fasciitis, and other musculoskeletal conditions that reduce mobility. The company markets, sells, and services peripheral quantitative computed tomography bone and muscle measurement systems for research and clinical applications; patented motorized exercise systems for rehabilitation, physical therapy, and sports medicine based on patented vibration technology; human performance measurement systems for monitoring improvement in power and mobility; and extracorporeal shock wave therapy systems for non-invasive treatment of pain associated with plantar fasciitis. It also markets, sells, and services patented motorized exercise systems to professional teams, fitness centers, gyms, sports clubs, and wellness-conscious general public.
Orthometrix, Inc. Fundamentals Summary
| OMRX fundamental statistics | |
|---|---|
| Market cap | US$53.00 |
| Earnings (TTM) | -US$959.26k |
| Revenue (TTM) | US$1.46m |
0.0x
P/S Ratio0.0x
P/E RatioIs OMRX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OMRX income statement (TTM) | |
|---|---|
| Revenue | US$1.46m |
| Cost of Revenue | US$865.69k |
| Gross Profit | US$591.06k |
| Other Expenses | US$1.55m |
| Earnings | -US$959.26k |
Last Reported Earnings
Sep 30, 2008
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did OMRX perform over the long term?
See historical performance and comparison